» Articles » PMID: 2866450

Direct Labelling of Beta 2-adrenoceptors. Comparison of Binding Potency of 3H-ICI 118,551 and Blocking Potency of ICI 118,551

Overview
Specialty Pharmacology
Date 1985 Oct 1
PMID 2866450
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

A radioligand that selectively labels beta 2-adrenoceptors, 3H-ICI 118,551 (3H-ICI), is introduced. Experiments were performed on guinea-pig tissues. The binding characteristics of 3H-ICI on lung membrane particles are compared with the blocking characteristics of ICI 118,551 against the tracheo-relaxant effects of (-)-noradrenaline, (-)-adrenaline and (+/-)-fenoterol. Binding to both beta 1- and beta 2-adrenoceptors were also performed with 3H-(-)-bupranolol on lung and ventricular myocardium. The binding inhibition characteristics of unlabelled ICI 118,551 on ventricle were compared with its characteristics as antagonist of the positive chronotropic effects of (-)-noradrenaline, (-)-adrenaline and (+/-)-fenoterol in spontaneously beating right atria. 1. ICI 118,551 blocked more the relaxant effects of (+/-)-fenoterol and (-)-adrenaline than those of (-)-noradrenaline on trachea. The positive chronotropic effects of (+/-)-fenoterol on sinoatrial node were blocked more than those of both (-)-adrenaline and (-)-noradrenaline. A non-linear regression analysis of blocking data with ICI 118,551 according to the model of Lemoine and Kaumann (1983) revelas that both beta 1- and beta 2-adrenoceptors contribute to the tracheo-relaxant and positive chronotropic effects of agonists. The estimated equilibrium dissociation constants pKB (-log KB = pKB; mol/l) were 7.1 and 9.6 for beta 1- and beta 2-adrenoceptors, respectively. Tracheal beta 2-adrenoceptors contribute 99%, 97% and 7%, sinoatrial beta 2-adrenoceptors contribute 76%, 3% and 0% to the fractional stimuli induced by (+/-)-fenoterol, (-)-adrenaline and (-)-noradrenaline, respectively. 2. 3H-ICI associated to beta 2-adrenoceptors of lung membranes with a kon of 0.521 X nmol-1 X min-1 and dissociated with a koff of 0.19 min-1. 3H-ICI bound to lung beta 2-adrenoceptors with an equilibrium dissociation constant pKL* of 9.2. Unlabelled ICI 118,551, (-)-bupranolol, (+)-bupranolol, (-)-adrenaline, (-)-noradrenaline and (+/-)-fenoterol competed with 3H-ICI for lung beta 2-adrenoceptors with pKL-values of 9.0, 9.4, 8.1, 5.9, 4.9 and 6.4, respectively. 3. 3H-(-)-bupranolol associated to beta-adrenoceptors of lung membranes with a kon 1.21 X nmol-1 X min-1 and dissociated with a koff of 0.26 min-1. 3H-(-)-bupranolol bound to lung beta 2-adrenoceptors and to heart beta 1-adrenoceptors with a pKL of 9.6 and a pKL of 8.8, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)

Citing Articles

The β -adrenoceptor agonist mirabegron increases human atrial force through β -adrenoceptors: an indirect mechanism?.

Mo W, Michel M, Lee X, Kaumann A, Molenaar P Br J Pharmacol. 2017; 174(16):2706-2715.

PMID: 28574581 PMC: 5522995. DOI: 10.1111/bph.13897.


Asynchronous activation of calcium and potassium currents by isoproterenol in canine ventricular myocytes.

Ruzsnavszky F, Hegyi B, Kistamas K, Vaczi K, Horvath B, Szentandrassy N Naunyn Schmiedebergs Arch Pharmacol. 2014; 387(5):457-67.

PMID: 24566722 DOI: 10.1007/s00210-014-0964-6.


Pharmacological characterization of the beta-adrenoceptor that mediates the relaxant response to noradrenaline in guinea-pig tracheal smooth muscle.

Tanaka Y, Yamashita Y, Michikawa H, Horinouchi T, Koike K Naunyn Schmiedebergs Arch Pharmacol. 2007; 375(1):51-64.

PMID: 17237919 DOI: 10.1007/s00210-006-0130-x.


Comparison of three radioligands for the labelling of human beta-adrenoceptor subtypes.

Niclauss N, Michel-Reher M, Alewijnse A, Michel M Naunyn Schmiedebergs Arch Pharmacol. 2006; 374(2):99-105.

PMID: 17028849 DOI: 10.1007/s00210-006-0104-z.


Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes.

Ponicke K, Groner F, Heinroth-Hoffmann I, Brodde O Br J Pharmacol. 2006; 147(7):714-9.

PMID: 16474418 PMC: 1751514. DOI: 10.1038/sj.bjp.0706674.


References
1.
Ehle B, Lemoine H, Kaumann A . Improved evaluation of binding of ligands to membranes containing several receptor-subtypes. Naunyn Schmiedebergs Arch Pharmacol. 1985; 331(1):52-9. DOI: 10.1007/BF00498851. View

2.
Kaumann A, Lemoine H . Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency. Naunyn Schmiedebergs Arch Pharmacol. 1985; 331(1):27-39. DOI: 10.1007/BF00498849. View

3.
Lemoine H, Kaumann A . A model for the interaction of competitive antagonists with two receptor-subtypes characterized by a Schild-plot with apparent slope unity. Agonist-dependent enantiomeric affinity ratios for bupranolol in tracheae but not in right atria of guinea.... Naunyn Schmiedebergs Arch Pharmacol. 1983; 322(2):111-20. DOI: 10.1007/BF00512383. View

4.
Kaumann A, Marano M . On equilibrium dissociation constants for complexes of drug-receptor subtypes. Selective and non-selective interactions of partial agonists with two plausible beta-adrenoceptor subtypes mediating positive chronotropic effects of (-)-isoprenaline in.... Naunyn Schmiedebergs Arch Pharmacol. 1982; 318(3):192-201. DOI: 10.1007/BF00500480. View

5.
Morris T, Sandrock K, Kaumann A . 3H-(-)-Bupranolol, a new beta-adrenoceptor radioligand: characterization of its binding to kitten heart beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1981; 317(1):19-25. DOI: 10.1007/BF00506251. View